# Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)

> **NCT00336505** · PHASE3 · COMPLETED · sponsor: **Advanced Life Sciences, Inc.** · enrollment: 584 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Cethromycin
- **DRUG:** Clarithromycin

## Key facts

- **NCT ID:** NCT00336505
- **Lead sponsor:** Advanced Life Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-12
- **Primary completion:** 2007-10
- **Final completion:** 2007-10
- **Target enrollment:** 584 (ACTUAL)
- **Last updated:** 2010-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00336505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00336505, "Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia (CAP)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT00336505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*